Use of antidepressants for management of hot flashes (Q37621555)

21 August 2017

1 reference

title

Use of antidepressants for management of hot flashes (English)

1 reference

21 August 2017

Dana G Carroll

1

1 reference

21 August 2017

Kristi W Kelley

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

29

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

1357-1374

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

The role of serotonin in hot flushes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Hypothesis: pathogenesis of postmenopausal hot flush

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Phase III evaluation of fluoxetine for treatment of hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Constructing a standard climacteric scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

A new methodological approach to the evaluation of quality of life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Nonhormonal alternatives for the treatment of hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Venlafaxine for the control of hot flashes: results of a longitudinal continuation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Paroxetine versus placebo for women in midlife after hormone therapy discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Efficacy of citalopram on climacteric symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

BioPsychoSocial Medicine: a new open access journal

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Treatment of hot flushes with mirtazapine: four case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Mirtazapine for the treatment of hot flushes in breast cancer survivors: a prospective pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1357

21 January 2018

Identifiers

DOI

10.1592/PHCO.29.11.1357

1 reference

21 August 2017

1 reference